Want to see MWAI full AI Analyst Report?
MWAI Stock Chart & Stats
$0.35
$0.00(0.00%)
At close: 4:00 PM EDT
$0.35
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.20 - $0.80
Previous CloseN/A
Volume3.92K
Average Volume (3M)4.51K
Market Cap
$2.29M
Enterprise Value$2.07M
Total Cash (Recent Filing)$223.22K
Total Debt (Recent Filing)$600.30K
Price to Earnings (P/E)―
Beta0.55
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding6,536,580
10 Day Avg. Volume2,376
30 Day Avg. Volume4,515
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.81
Price to Sales (P/S)3.42
P/FCF Ratio-2.17
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue3.00
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda-0.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Absolute Debt BurdenLow nominal debt (≈$0.6M) reduces fixed financing costs and interest burden, providing structural flexibility to manage short-term obligations and pursue restructuring or product investment. Over a 2–6 month horizon this limits default risk versus highly leveraged peers and eases near-term refinancing pressure.
Improving Cash Burn TrendA material improvement in cash burn from 2024 to 2025 indicates management progress on expense control or working capital. While cash flow remains negative, this structural improvement reduces near-term external funding needs and signals a clearer runway to test business-model adjustments over the next few months.
High Reported Gross Margin In 2025A high gross margin implies the core product or service has scalable unit economics typical of software/healthcare-information offerings. If top-line stability returns, this margin profile can drive operating leverage and faster path to profitability, making the business structurally attractive long term.
Bears Say
Severe Revenue DeclineA ~61% YoY revenue drop is a durable red flag: it erodes unit economics, undercuts pricing power and market position, and impairs ability to leverage fixed-cost infrastructure. Such a large structural top-line contraction makes achieving sustainable margins and predictable cash generation much harder over the medium term.
Consistent Losses And Negative EquityMulti-year accumulated losses producing negative shareholder equity weaken solvency and reduce access to traditional capital markets. This structural impairment increases reliance on dilutive financing or strategic exits, limiting flexibility for investments and heightening insolvency risk if losses persist.
Persistent Negative Operating And Free Cash FlowOngoing negative operating and free cash flows create a durable funding gap, forcing dependence on external capital or asset sales. A ~47% deterioration in free cash flow in 2025 underscores weaker internal funding capacity, raising the probability of dilution and constraining strategic investments over coming months.
MedWellAI News
MWAI FAQ
What was MedWellAI’s price range in the past 12 months?
MedWellAI lowest stock price was $0.20 and its highest was $0.80 in the past 12 months.
What is MedWellAI’s market cap?
MedWellAI’s market cap is $2.29M.
When is MedWellAI’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MedWellAI’s earnings last quarter?
MedWellAI released its earnings results on Feb 18, 2025. The company reported -$0.127 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.127.
Is MedWellAI overvalued?
According to Wall Street analysts MedWellAI’s price is currently Overvalued.
Does MedWellAI pay dividends?
MedWellAI does not currently pay dividends.
What is MedWellAI’s EPS estimate?
MedWellAI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedWellAI have?
MedWellAI has 6,536,580 shares outstanding.
What happened to MedWellAI’s price movement after its last earnings report?
MedWellAI reported an EPS of -$0.127 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MedWellAI?
Currently, no hedge funds are holding shares in MWAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedWellAI
MedWellAI Inc., through its subsidiary, develops, acquires, operates, and invests in businesses. It provides AI-driven healthcare and wellness solutions. The company also offers a B2B e-commerce platform for distributing pharmaceutical products, particularly GLP medications for weight loss and diabetes management. In addition, it provides an AI-powered ordering system with inventory tracking, smart suggestions, and support for healthcare providers such as wellness clinics, med spas, and corporate wellness facilities. The company was formerly known as Integrated Ventures, Inc. and changed its name to MedWellAI Inc. in June 2025. The company is based in Clearwater, Florida.
Technical Analysis
Nvni Group
―
Xiao-I Corp. ADR
―
Simpple Ltd.
―
Health In Tech, Inc. Class A
―
Cloudastructure, Inc. Class A
―